In conclusion, high plasma levels of FGF-23 are associated with certain demographics, such as age and sex; with cardiovascular diseases like LVH, HF and AF; with clinical disturbances such as low eGFR, high phosphate and NT-pro-BNP; and with comorbidities like diabetes and hypertension. This evidence concerns the gene NPPB and hydrops fetalis.